Ruscica M - Search Results

1

Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP).

Rizzo M, Colletti A, Penson PE, Katsiki N, Mikhailidis DP, Toth PP, Gouni-Berthold I, Mancini J, Marais D, Moriarty P, Ruscica M, Sahebkar A, Vinereanu D, Cicero AFG, Banach M; International Lipid Expert Panel (ILEP). Rizzo M, et al. Among authors: ruscica m. Pharmacol Res. 2023 Mar;189:106679. doi: 10.1016/j.phrs.2023.106679. Epub 2023 Feb 8. Pharmacol Res. 2023. PMID: 36764041 Free article. Review.

2

Adipokines and sexual hormones associated with the components of the metabolic syndrome in pharmacologically untreated subjects: data from the brisighella heart study.

Cicero AF, Magni P, Moré M, Ruscica M, Dozio E, Steffani L, Borghi C, Strollo F. Cicero AF, et al. Among authors: ruscica m. Int J Endocrinol. 2011;2011:724816. doi: 10.1155/2011/724816. Epub 2011 Nov 9. Int J Endocrinol. 2011. PMID: 22114592 Free PMC article.

3

Nutraceutical approach to moderate cardiometabolic risk: results of a randomized, double-blind and crossover study with Armolipid Plus.

Ruscica M, Gomaraschi M, Mombelli G, Macchi C, Bosisio R, Pazzucconi F, Pavanello C, Calabresi L, Arnoldi A, Sirtori CR, Magni P. Ruscica M, et al. J Clin Lipidol. 2014 Jan-Feb;8(1):61-8. doi: 10.1016/j.jacl.2013.11.003. Epub 2013 Nov 11. J Clin Lipidol. 2014. PMID: 24528686 Clinical Trial.

4

Statin therapy and related risk of new-onset type 2 diabetes mellitus.

Ruscica M, Macchi C, Morlotti B, Sirtori CR, Magni P. Ruscica M, et al. Eur J Intern Med. 2014 Jun;25(5):401-6. doi: 10.1016/j.ejim.2014.03.003. Epub 2014 Mar 27. Eur J Intern Med. 2014. PMID: 24685426 Review.

5

Risk identification and possible countermeasures for muscle adverse effects during statin therapy.

Magni P, Macchi C, Morlotti B, Sirtori CR, Ruscica M. Magni P, et al. Among authors: ruscica m. Eur J Intern Med. 2015 Mar;26(2):82-8. doi: 10.1016/j.ejim.2015.01.002. Epub 2015 Jan 29. Eur J Intern Med. 2015. PMID: 25640999 Review.

6

Non-insulin anti-diabetic drugs: An update on pharmacological interactions.

Ruscica M, Baldessin L, Boccia D, Racagni G, Mitro N. Ruscica M, et al. Pharmacol Res. 2017 Jan;115:14-24. doi: 10.1016/j.phrs.2016.11.005. Epub 2016 Nov 9. Pharmacol Res. 2017. PMID: 27838511 Review.

7

Bococizumab for the treatment of hypercholesterolaemia.

Ferri N, Corsini A, Sirtori CR, Ruscica M. Ferri N, et al. Among authors: ruscica m. Expert Opin Biol Ther. 2017 Feb;17(2):237-243. doi: 10.1080/14712598.2017.1279602. Expert Opin Biol Ther. 2017. PMID: 28060539 Free article. Review.

8

PPAR-α agonists are still on the rise: an update on clinical and experimental findings.

Ferri N, Corsini A, Sirtori C, Ruscica M. Ferri N, et al. Among authors: ruscica m. Expert Opin Investig Drugs. 2017 May;26(5):593-602. doi: 10.1080/13543784.2017.1312339. Epub 2017 Apr 11. Expert Opin Investig Drugs. 2017. PMID: 28343425 Review.

9

Bococizumab for the treatment of hypercholesterolaemia.

Ferri N, Corsini A, Sirtori CR, Ruscica M. Ferri N, et al. Among authors: ruscica m. Expert Opin Biol Ther. 2017 Jul;17(7):909-910. doi: 10.1080/14712598.2017.1330849. Epub 2017 May 29. Expert Opin Biol Ther. 2017. PMID: 28552009 No abstract available.

10

Nutraceutical approaches to metabolic syndrome.

Sirtori CR, Pavanello C, Calabresi L, Ruscica M. Sirtori CR, et al. Among authors: ruscica m. Ann Med. 2017 Dec;49(8):678-697. doi: 10.1080/07853890.2017.1366042. Epub 2017 Aug 22. Ann Med. 2017. PMID: 28786719 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

219 results

Search Page